Jeffrey S. Parkin

Array ( [id] => 7184957 [patent_doc_number] => 20050191703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication' [patent_app_type] => utility [patent_app_number] => 10/724273 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 14667 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191703.pdf [firstpage_image] =>[orig_patent_app_number] => 10724273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938575 [patent_doc_number] => 20050112138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Aids vaccines' [patent_app_type] => utility [patent_app_number] => 10/719004 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5428 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112138.pdf [firstpage_image] =>[orig_patent_app_number] => 10719004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 474371 [patent_doc_number] => 07226602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-05 [patent_title] => 'Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses' [patent_app_type] => utility [patent_app_number] => 10/719547 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 47502 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/226/07226602.pdf [firstpage_image] =>[orig_patent_app_number] => 10719547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7185112 [patent_doc_number] => 20050191729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Methods for the recombinant production of antifusogenic peptides' [patent_app_type] => utility [patent_app_number] => 10/716095 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8767 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191729.pdf [firstpage_image] =>[orig_patent_app_number] => 10716095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432297 [patent_doc_number] => 07897332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Methods for the detection of HIV-1 or -2 antigens employing monoclonal antibodies that recognize a shared HIV-1/-2 epitope in the capsid p24/p26 proteins' [patent_app_type] => utility [patent_app_number] => 10/714689 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 13824 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 547 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897332.pdf [firstpage_image] =>[orig_patent_app_number] => 10714689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291207 [patent_doc_number] => 20040110774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Methods and formulations of using A1 adenosine receptor antagonists and P2x purinoceptor antagonists for the treatment and prevention of immune system disorders' [patent_app_type] => new [patent_app_number] => 10/713860 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7118 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110774.pdf [firstpage_image] =>[orig_patent_app_number] => 10713860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7307509 [patent_doc_number] => 20040141996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Compositions and methods for treating viral infections' [patent_app_type] => new [patent_app_number] => 10/695112 [patent_app_country] => US [patent_app_date] => 2003-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26543 [patent_no_of_claims] => 158 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141996.pdf [firstpage_image] =>[orig_patent_app_number] => 10695112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675241 [patent_doc_number] => 20040126877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Repressors for hiv transcription and methods thereof' [patent_app_type] => new [patent_app_number] => 10/475681 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4222 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126877.pdf [firstpage_image] =>[orig_patent_app_number] => 10475681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7126894 [patent_doc_number] => 20050058638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Biosynthetic binding proteins for immuno-targeting' [patent_app_type] => utility [patent_app_number] => 10/683547 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20022 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20050058638.pdf [firstpage_image] =>[orig_patent_app_number] => 10683547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7385917 [patent_doc_number] => 20040180329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Synthetic HIV gag genes' [patent_app_type] => new [patent_app_number] => 10/678926 [patent_app_country] => US [patent_app_date] => 2003-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11887 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180329.pdf [firstpage_image] =>[orig_patent_app_number] => 10678926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7335093 [patent_doc_number] => 20040132161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Methods and compositions for increasing CD4lymphocyte immune responsiveness' [patent_app_type] => new [patent_app_number] => 10/673882 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 27860 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132161.pdf [firstpage_image] =>[orig_patent_app_number] => 10673882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843079 [patent_doc_number] => 20060121480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome' [patent_app_type] => utility [patent_app_number] => 10/529051 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6298 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121480.pdf [firstpage_image] =>[orig_patent_app_number] => 10529051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7475109 [patent_doc_number] => 20040122214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Conjugates comprised of polymer and HIV gp41-derived peptides and their use in therapy' [patent_app_type] => new [patent_app_number] => 10/671282 [patent_app_country] => US [patent_app_date] => 2003-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13766 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122214.pdf [firstpage_image] =>[orig_patent_app_number] => 10671282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7363777 [patent_doc_number] => 20040091855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Method for production of antivirals by use of HIV-derived HR1 peptides, and trimers formed therefrom' [patent_app_type] => new [patent_app_number] => 10/671316 [patent_app_country] => US [patent_app_date] => 2003-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16272 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091855.pdf [firstpage_image] =>[orig_patent_app_number] => 10671316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256082 [patent_doc_number] => 07575750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'Human immunodeficiency virus (HIV) gp41 peptide derivatives with enhanced solubility and antiviral activity' [patent_app_type] => utility [patent_app_number] => 10/667966 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14252 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/575/07575750.pdf [firstpage_image] =>[orig_patent_app_number] => 10667966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 101860 [patent_doc_number] => 07727757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Methods of eliciting antiviral immune responses utilizing viral particles comprising photoinactivated reverse transcriptase' [patent_app_type] => utility [patent_app_number] => 10/667534 [patent_app_country] => US [patent_app_date] => 2003-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15078 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/727/07727757.pdf [firstpage_image] =>[orig_patent_app_number] => 10667534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7280379 [patent_doc_number] => 20040062756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Methods for stable transduction of cells with viral vectors' [patent_app_type] => new [patent_app_number] => 10/664331 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14485 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20040062756.pdf [firstpage_image] =>[orig_patent_app_number] => 10664331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7164849 [patent_doc_number] => 20040076637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'HIV-derived HR1 peptides modified to form stable trimers, and their use in therapy to inhibit transmission of human immunodeficiency virus' [patent_app_type] => new [patent_app_number] => 10/664021 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17612 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20040076637.pdf [firstpage_image] =>[orig_patent_app_number] => 10664021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 902602 [patent_doc_number] => 07335468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'TSG101-GAG interaction and use thereof' [patent_app_type] => utility [patent_app_number] => 10/663407 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 42014 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335468.pdf [firstpage_image] =>[orig_patent_app_number] => 10663407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306805 [patent_doc_number] => 20040116660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Process for the selection of hiv-1 subtype c Isolates, selected hiv-1 subtype c isolates, their genes and modifications and derivatives thereof' [patent_app_type] => new [patent_app_number] => 10/332413 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 8523 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116660.pdf [firstpage_image] =>[orig_patent_app_number] => 10332413 [rel_patent_id] =>[rel_patent_doc_number] =>)